Opt Health Vs Superpower

Opt Health and Superpower sit at opposite ends of the same category. Superpower spends its product effort on the interface: guided onboarding, coaching prompts, and a fast-moving app wrapped around 100+ biomarkers for $499 a year. Opt Health spends its product effort on the clinician: a 55+ marker panel, a physician consult, a written protocol, and a retest every 3–4 months for roughly $3,000. Both hand you numbers. Only one hands you a prescription.

Public litigation

Superpower Health is the defendant in Function Health’s open Lanham Act / false-advertising suit (C.D. Cal., filed January 2026). Allegations only — Justia docket 2:26-cv-00810.

What each platform actually is

Opt Health

Opt Health sells a single cash-pay membership at around $3,000 a year, built for adults over 40. Physicians run the clinical side and consult time is inside the price rather than metered. The tangible deliverable is a 55+ marker panel across hormones, metabolic markers, inflammation, and nutrients, collected by an at-home phlebotomist in most markets, followed by a protocol that may include testosterone replacement, peptides, a GLP-1, or a supplement stack. Labs repeat every 3–4 months and the protocol moves with them. Opt Health does not sell the panel on its own, does not run a consumer engagement app as its main product, does not bill insurance, and does not cover the cost of the medication it prescribes.

Superpower

Superpower sells a $499 annual membership positioned as the app-first entry to biomarker testing. The clinical layer is written commentary attached to results, with live physician and specialist sessions available as $150–$300 add-ons. The tangible deliverable is two draws a year covering 100+ biomarkers, taken at a Quest partner location or by an at-home phlebotomist in select markets, presented in a mobile app with guided onboarding and prompts against flagged results, plus a full download of the raw values. Superpower does not prescribe, does not manage a treatment protocol, and does not bill insurance. Retests between the two included draws are purchased per panel.

Side by side on the standard rubric

Nine criteria, applied identically to both platforms using the figures each one publishes.

What each actually costs

Opt Health prices as a single bundle with no stated one-time onboarding fee, so year two opens at the same ~$3,000 as year one. What moves the total is pharmacy, not the platform. A compounded GLP-1 at $200–$400 a month adds $2,400–$4,800 across a year; a supplement-only protocol adds comparatively little. That spread is the whole reason the realistic year-one figure is written as a $3,000–$6,000 range. It is also why year two can fall below year one for the same member: end the GLP-1 course and the ongoing cost settles back toward the membership line, with the panel and consults unchanged.

Superpower likewise carries no stated one-time onboarding fee, so year two restarts at $499. The published pattern is that base-only members pay $499 flat, most members reach $650–$800 after a single consult, and a member who adds a panel lands in the $750–$1,200 band. The lever people underestimate is the between-draw retest, priced per panel: the app is designed to prompt action on a flagged result, and checking whether that action worked is a purchase, not an inclusion. Two or three of those in a year moves Superpower out of its own headline price band.

Where Opt Health leads

• Physician consult inside the price. A one-on-one session with a physician is part of the membership rather than a $150–$300 purchase per conversation.
• Prescription pathway. TRT, peptides, GLP-1 medications, and supplement protocols are written from your own values without a referral out.
• Reassessment is scheduled, not bought. Labs re-run every 3–4 months as part of the membership, so checking whether a change worked is not a separate transaction.
• One price covers the service layer. There is no menu of panels, chats, and consults to price against each other during the year.
• Draw comes to you in most markets. At-home phlebotomy is the default rather than a select-market option.

Where Superpower leads

• Onboarding built for first-timers. The guided flow assumes no prior familiarity with lab work, which is the point at which most people abandon a results portal.
• Entry price. $499 covers the full year and 100+ markers if you decline every add-on, and declining every add-on is a supported way to use the product.
• Panel breadth. 100+ biomarkers in the base membership against Opt Health's 55+, covering more systems per draw.
• Retest flexibility. Targeted panels can be bought between the two included draws, so you can check one marker without waiting six months.
• Data portability. Raw results download in full, which keeps the values usable by any clinician you take them to later.

Trade-offs to weigh

Opt Health trade-offs

• The bundle is all-or-nothing. There is no way to buy the 55+ panel alone at a lower price, so a member who wants only testing pays for physician time regardless.
• Fewer markers per draw. 55+ is a curated hormone, metabolic, inflammation, and nutrient set, which leaves out coverage a 100+ panel includes.
• Built around a specific member. The product is designed for adults over 40 arriving with symptoms; an asymptomatic 32-year-old is paying for a treatment loop that may never produce a prescription.
• Cash-pay with a separate pharmacy bill. No insurance channel exists, and the medication the protocol calls for is charged on top of the ~$3,000.

Superpower trade-offs

• No prescription pathway. A flagged hormone or metabolic result ends in a recommendation, and finding and paying a prescriber is a separate project.
• Physician time is metered. Every live conversation is a $150–$300 or higher purchase, so the cost of asking follow-up questions scales with how many you have.
• At-home draws are market-dependent. Outside select markets the draw means a trip to a Quest partner location on their schedule.
• Engagement and spend move together. The app is built to prompt action, and the actions it can offer are add-on panels, consults, and retests.

Who should pick each

Pick Opt Health if: you are over 40, symptoms rather than curiosity are driving the purchase, and you want the person interpreting the panel to be the person who can prescribe against it. You accept roughly $3,000 before pharmacy costs, you want retesting every 3–4 months without deciding what to buy each time, and you would rather not assemble a testing service, a cash-pay physician, and a pharmacy into a working system yourself.

Pick Superpower if: you are under 45 or asymptomatic, you want the widest panel available for the smallest outlay, and your real obstacle is staying engaged with health data rather than getting access to a doctor. You are comfortable reading written commentary, you have a physician elsewhere if something needs treating, and you would rather buy a consult or a retest occasionally than carry a bundled fee all year.

Who should pick neither

Neither product touches insurance, and both assume you want more than a standard annual physical produces. If you are buying to answer one defined question, or if cost is the binding constraint, another route usually gets you there for less.

• Your employer or plan annual physical. A covered visit already includes a CBC, CMP, lipid panel, and often thyroid and A1c. Starting there costs a copay and tells you whether a broader panel is even warranted.
• A specialist referral. Recurrent migraines, suspected sleep apnea, or a suspicious skin lesion are answered by the relevant specialist, not by a wider blood panel.
• Function Health — the other $499 membership with a 100+ panel and a more clinical dashboard, if the app layer is not what you are buying.
• Hone Health and Lifeforce — listed alphabetically, the hormone-focused and mid-priced clinician-led options between these two price bands.

Can you use both?

Running both costs about $3,500 a year before medication and before any Superpower add-on, and the overlap is substantial. Both memberships include their own blood draws, and both cover hormones, metabolic markers, inflammation, and nutrients. Superpower's app is built around Superpower's own draws, so seeing your values inside that interface means paying for its collection, not importing Opt Health's. You end up with two panels, two schedules, and one prescriber — while paying twice for the part where the blood comes out of your arm.

The one arrangement that holds up is a single Superpower year used as a wide baseline before an Opt Health membership begins. That gives a physician a broader starting picture than 55+ markers alone, costs $499 once rather than every year, and does not duplicate a draw because the two are months apart. Beyond that, the test is whether you would open the Superpower app in a month where your protocol is not changing. If the answer is no, the second membership is buying an interface you are not using.

What the rubric does not capture

A table cannot show what happens in the gap between a flagged result and a changed behavior. Superpower closes that gap with software: a prompt, a suggested action, a nudge to retest. Opt Health closes it with a scheduled appointment and a protocol document. Software scales and is always available at 11pm; a physician does not scale but can weigh your ferritin against your thyroid panel and your sleep in one judgment. Neither mechanism is stronger in the abstract — they fail differently. Prompts get dismissed. Appointments get rescheduled.

Availability is the second thing the rubric flattens. Opt Health lists at-home phlebotomy in most markets and Superpower in select markets, which reads like a minor row until you live somewhere neither covers well. In a dense metro both are frictionless. Outside one, Superpower means a Quest trip and Opt Health means checking whether a phlebotomist serves your area at all. That single logistical fact decides more cancellations than any feature comparison, and it is invisible in a national price.

Cancellation asymmetry is the third. Ending a Superpower year is a clean stop: you keep the exported results and lose an interface. Ending an Opt Health year stops a clinical relationship, and if a protocol is live the sequencing matters — a titrating dose needs a receiving prescriber before the membership lapses, not after. That is not a criticism of either pricing model, but it is a real difference in what "just cancel" means, and it belongs in the decision before the first payment rather than eleven months into it.

Related

• Full Opt Health review
• Full Superpower review
• Opt Health cost breakdown
• Superpower cost breakdown
• Function Health vs Superpower
• Opt Health vs Function Health
• Is Superpower worth it?
• All doctor-led options compared